Transcatheter Aortic Valve Replacement Market Trends That Will Shape the Next Decade: Insights from Innovative Advancements In Transcatheter Aortic Valve Replacement Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Transcatheter Aortic Valve Replacement Market Size By 2025?
The market for transcatheter aortic valve replacement has been increasing at a swift pace in the past few years. It's expected to escalate from $5.19 billion in 2024, reaching $5.87 billion in 2025, with a compound annual growth rate (CAGR) of 13.2%. Factors such as the growing instances of aortic regurgitation, the escalating occurrence of cardiovascular diseases, a rising patient inclination towards less invasive treatments, global growth of TAVR procedures, and advantageous reimbursement policies have contributed to the historical growth.

How Big Is the Transcatheter Aortic Valve Replacement Market Size Expected to Grow by 2029?
The market size for Transcatheter Aortic Valve Replacement is anticipated to exhibit swift expansion in the forthcoming years. The market is projected to reach a valuation of $9.99 billion in 2029, rising at a Compound Annual Growth Rate of 14.2%. This predicted growth during the forecast period may be due to several factors, including an increase in cases of aortic stenosis, a growing preference for minimally invasive procedures, an increased range of TAVR procedure indications, encouraging reimbursement policies, and increasing recognition of TAVR as a viable treatment option. Key trends during the forecast period include the ongoing advancement of device technology, a rising incidence of cardiovascular diseases, worldwide expansion of TAVR procedures, an older demographic, and a surge in healthcare spending.

View the full report here:
https://www.thebusinessresearchcompany.com/report/transcatheter-aortic-valve-replacement-global-market-report

Which Key Market Drivers Powering Transcatheter Aortic Valve Replacement Market Expansion and Growth?
One of the key contributors to the rise of the transcatheter aortic valve replacement market is the growing occurrence of aortic stenosis. This is a medical issue characterized by a narrowing of the aortic valve in the heart. Transcatheter aortic valve replacement (TAVR) offers a less invasive solution for this, compared to surgical aortic valve replacement (SAVR). It assists in re-establishing blood circulation and minimizing the indications and symptoms of aortic valve stenosis. For example, data from the American Heart Association, as of May 2024, showed that over 12% of elderly Americans are afflicted by aortic stenosis. This is a problem commonly seen in those over 65, and if left untreated, it could lead to heart failure and even death. Also, according to a March 2023 report from the National Institute for Health and Care Excellence (NICE) in the UK, about 1.5% of individuals over 55 in the UK, amounting to roughly 300,000 people, are living with severe aortic stenosis. Slightly less than 200,000 among them have the symptomatic condition and need treatment. This has resulted in over 380,000 individuals on cardiac waiting lists by March 2023. Hence, the rise in aortic stenosis prevalence is propelling the transcatheter aortic valve replacement market forward.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12031&type=smp

What Trends Will Shape the Transcatheter Aortic Valve Replacement Market Through 2029 and Beyond?
Product advancement is an emerging trend within the Transcatheter Aortic Valve Replacement (TAVR) market. Businesses within this sector are concentrating their efforts on the evolution of new technology and inventive solutions to reinforce their market standing. In a notable instance from May 2024, Edwards Lifesciences, a US medical technology establishment, initiated the entry of the Sapien 3 Ultra Resilia valve into the European market. This marked the introduction of the only TAVR system boasting the firm's Resilia tissue technology. This ground-breaking technology increases the lifespan of the valve by utilizing bovine pericardial tissue that has undergone anti-calcification treatment. By integrating this solution that inhibits calcium, the Resilia technology can curtail structural valve deterioration, which is a predominant reason for reintervention post valve replacement.

What Are the Emerging Segments in the Transcatheter Aortic Valve Replacement Market?
The transcatheter aortic valve replacement market covered in this report is segmented -

1) By Product: Self-Expandable Transcatheter Aortic Valves, Balloon-Expandable Transcatheter Aortic Valves, Mechanically Expanded Transcatheter Aortic Valves
2) By Material: Valve Frame Material, Valve Leaflet Material
3) By Procedure: Transfemoral Implantation, Transapical Implantation, Transaortic Implantation
4) By Application: Aortic Stenosis, Aortic Regurgitation, Other Applications
5) By End-User: Hospitals, Independent Cardiac Catheterization Labs, Ambulatory Surgical Centers, Other End-Users

Subsegments:
1) By Self-Expandable Transcatheter Aortic Valves: Nitinol Frame Self-Expandable Valves, Polyester and Polyurethane Coated Valves
2) By Balloon-Expandable Transcatheter Aortic Valves: Balloon-Expandable Valves with Stent Design, Resilient Balloon-Expandable Valves
3) By Mechanically Expanded Transcatheter Aortic Valves: Manually Expanded Valves, Mechanically Operated Valve Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12031&type=smp

Who Are the Global Leaders in the Transcatheter Aortic Valve Replacement Market?
Major companies operating in the transcatheter aortic valve replacement market include Abbott Laboratories Inc., Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova PLC, Meril Life Sciences Pvt. Ltd., Venus MedTech HangZhou Inc, Braile Biomedica, Peijia Medical Limited, Direct Flow Medical Inc., Transcatheter Technologies GmbH, Symetis SA, JenaValve Technology Inc., Micro Interventional Devices Inc., Xeltis BV, Tendyne Holdings Inc., MVRx Inc., Keystone Heart Ltd., Colibri Heart Valve LLC, HighLife SAS, Neovasc Inc., Aegis Surgical Limited, Foldax Inc., MValve Technologies Ltd., NaviGate Cardiac Structures Inc.

Which are the Top Profitable Regional Markets for the Transcatheter Aortic Valve Replacement Industry?
North America was the largest region in the transcatheter aortic valve replacement market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transcatheter aortic valve replacement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12031

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.